Publications by authors named "Ru Lv"
Article Synopsis
- A study was conducted to analyze the causes of pneumonia in both HIV-infected and HIV-uninfected patients using advanced testing methods on bronchoalveolar lavage fluid (BALF).
- The study involved 141 HIV-infected and 104 HIV-uninfected patients from January 2022 to May 2024, focusing on identifying various pathogens and assessing clinical data such as CD4 T-cell counts and treatment status.
- Results showed that HIV-uninfected patients were generally older and had more comorbidities, whereas HIV-infected patients had a higher prevalence of mixed-pathogen infections but lower TB detection rates; overall, the findings emphasized the importance of using mNGS and X-pert tests for timely pathogen identification in
Three-Directional Spacer-Knitted Piezoresistant Strain and Pressure Sensor for Electronic Integration and On-Body Applications.
ACS Appl Mater Interfaces
November 2023
The advancement of smart textiles has resulted in significant development in wearable textile sensors and offers novel interfaces to sense physical movements in daily life. Knitting, as a traditional textile fabrication method, is being used in promising ways to realize fully seamless fabrication and unobtrusive sensing in wearable textile applications. However, current flat-knitted sensors can sense strain only in the horizontal plane.
View Article and Find Full Text PDFCurrently, there are limited data related to the efficacy and safety of ART regimens, as well as factors influencing immune recovery in antiretroviral therapy (ART)-naïve patients with advanced HIV infection, especially in China. We designed a single-center, retrospective cohort study from March 1, 2019, to May 31, 2022, at The Second Hospital of Nanjing, China. ART-naïve adults with advanced HIV infection (CD4+ T-cell count < 200 cells/μL) who met the study criteria were included.
View Article and Find Full Text PDFBackground: Results from both clinical trials and real-world observational studies suggest that lamivudine plus dolutegravir (3TC + DTG) dual therapy has excellent virological efficacy and safety in HIV-1-infected patients. However, there is still no relevant study related to this dual therapy reported in China.
Methods: In this multicenter, retrospective, observational study that included HIV-1-infected patients in China, baseline and follow-up data were collected to analyze the virological suppression rate, immune restoration, and adverse events during follow-up in HIV-1-infected patients who switched to the 3TC + DTG dual therapy.
Background: The epidemiological and clinical characteristics of patients with coronavirus disease 2019 (COVID-19) have been reported. However, the prevalence of retesting positive by RT-PCR for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the associated patient characteristics, remain unclear.
Methods: We included 90 confirmed cases of COVID-19 treated in the Nanjing Public Health Center from January 20, 2020 to February 16, 2020 in this retrospective study.